Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report

Hepatic sinusoidal obstruction syndrome (HSOS) is often caused by the ingestion of pyrrolizidine alkaloids (PAs). To date, research on PAs-induced HSOS remains limited. Due to differing etiologies of HSOS in Western and Eastern populations, the clinical features, imaging findings, treatment approach...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Gao, Jingjing Zhang, Lei Zhu, Yaming Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1544400/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850144586978033664
author Bin Gao
Jingjing Zhang
Lei Zhu
Yaming Zhang
author_facet Bin Gao
Jingjing Zhang
Lei Zhu
Yaming Zhang
author_sort Bin Gao
collection DOAJ
description Hepatic sinusoidal obstruction syndrome (HSOS) is often caused by the ingestion of pyrrolizidine alkaloids (PAs). To date, research on PAs-induced HSOS remains limited. Due to differing etiologies of HSOS in Western and Eastern populations, the clinical features, imaging findings, treatment approaches, and outcomes of HSOS caused by hematopoietic stem cell transplantation or oxaliplatin may not be directly applicable to PAs-induced HSOS. PAs-induced HSOS commonly presents with painful hepatomegaly, ascites, and jaundice. Laboratory tests commonly show abnormal liver function in patients with PA-induced HSOS. Contrast-enhanced computed tomography and magnetic resonance imaging often reveal distinctive imaging features and significant histopathological liver changes in PAs-induced HSOS. These findings highlight the effectiveness of radiological imaging and liver biopsy as diagnostic tools. Treatment strategies for PAs-induced HSOS include fluid management, anticoagulation therapy, glucocorticoids, transjugular intrahepatic portosystemic shunt (TIPS), and liver transplantation. However, managing PAs-induced HSOS remains challenging. This paper presents the case of an elderly male diagnosed with gastric cancer complicated by hepatic sinusoidal obstruction syndrome. The diagnosis was based on characteristic imaging findings, a history of pyrrolizidine alkaloids ingestion, and standard diagnostic criteria, including liver biopsy and histological examination. The patient recovered fully after timely diagnosis and treatment, which included radical total gastrectomy, hepatoprotective diuretics, albumin supplementation, and low-molecular-weight heparin therapy.
format Article
id doaj-art-ad51a2cebc7245fd9bb13d92158995ec
institution OA Journals
issn 2296-858X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-ad51a2cebc7245fd9bb13d92158995ec2025-08-20T02:28:19ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-05-011210.3389/fmed.2025.15444001544400Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case reportBin GaoJingjing ZhangLei ZhuYaming ZhangHepatic sinusoidal obstruction syndrome (HSOS) is often caused by the ingestion of pyrrolizidine alkaloids (PAs). To date, research on PAs-induced HSOS remains limited. Due to differing etiologies of HSOS in Western and Eastern populations, the clinical features, imaging findings, treatment approaches, and outcomes of HSOS caused by hematopoietic stem cell transplantation or oxaliplatin may not be directly applicable to PAs-induced HSOS. PAs-induced HSOS commonly presents with painful hepatomegaly, ascites, and jaundice. Laboratory tests commonly show abnormal liver function in patients with PA-induced HSOS. Contrast-enhanced computed tomography and magnetic resonance imaging often reveal distinctive imaging features and significant histopathological liver changes in PAs-induced HSOS. These findings highlight the effectiveness of radiological imaging and liver biopsy as diagnostic tools. Treatment strategies for PAs-induced HSOS include fluid management, anticoagulation therapy, glucocorticoids, transjugular intrahepatic portosystemic shunt (TIPS), and liver transplantation. However, managing PAs-induced HSOS remains challenging. This paper presents the case of an elderly male diagnosed with gastric cancer complicated by hepatic sinusoidal obstruction syndrome. The diagnosis was based on characteristic imaging findings, a history of pyrrolizidine alkaloids ingestion, and standard diagnostic criteria, including liver biopsy and histological examination. The patient recovered fully after timely diagnosis and treatment, which included radical total gastrectomy, hepatoprotective diuretics, albumin supplementation, and low-molecular-weight heparin therapy.https://www.frontiersin.org/articles/10.3389/fmed.2025.1544400/fullhepatic sinusoidal obstruction syndromegastric cancerpyrrolizidine alkaloidsliver failureHSOS
spellingShingle Bin Gao
Jingjing Zhang
Lei Zhu
Yaming Zhang
Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report
Frontiers in Medicine
hepatic sinusoidal obstruction syndrome
gastric cancer
pyrrolizidine alkaloids
liver failure
HSOS
title Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report
title_full Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report
title_fullStr Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report
title_full_unstemmed Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report
title_short Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report
title_sort radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome a case report
topic hepatic sinusoidal obstruction syndrome
gastric cancer
pyrrolizidine alkaloids
liver failure
HSOS
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1544400/full
work_keys_str_mv AT bingao radicaltotalgastrectomyforgastriccancercomplicatedbyhepaticsinusoidalobstructionsyndromeacasereport
AT jingjingzhang radicaltotalgastrectomyforgastriccancercomplicatedbyhepaticsinusoidalobstructionsyndromeacasereport
AT leizhu radicaltotalgastrectomyforgastriccancercomplicatedbyhepaticsinusoidalobstructionsyndromeacasereport
AT yamingzhang radicaltotalgastrectomyforgastriccancercomplicatedbyhepaticsinusoidalobstructionsyndromeacasereport